← Back to Search

N/A

Almonds for Overweight Active Older Adults

N/A
Recruiting
Led By Bahram Arjmandi, PhD
Research Sponsored by Florida State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between the ages of 50-59 years
Free of any chronic diseases such as cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will study the effects of almond consumption on energy expenditure, performance, and related outcomes in active, overweight older adults, compared to a control snack.

Who is the study for?
This trial is for active, overweight adults aged 50-59 with a BMI of 25.0 to 29.9 kg/m2 who are free from chronic diseases like cancer and cardiovascular conditions. Participants should not be on certain medications, have musculoskeletal issues that limit activity, or be involved in other studies.Check my eligibility
What is being tested?
The study tests if eating almonds twice daily for 12 weeks can improve energy use, physical performance, vascular function, inflammation levels, sleep quality, mood status and body composition in active older adults compared to a similar calorie control snack.See study design
What are the potential side effects?
Potential side effects may include digestive discomfort or allergic reactions due to almond consumption; however specific side effects related to the intervention are not detailed in the provided information.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 50 and 59 years old.
Select...
I do not have any chronic diseases, including cancer.
Select...
I am a physically active man or a postmenopausal woman.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effect of almonds on functional performance
Effect of almonds on submaximal aerobic capacity (VO2)
Secondary outcome measures
Effect of Almond on arterial health using flow mediated dilation
Effect of Almond on arterial health using pulse wave velocity
Effect of Almond on oxidative stress
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Almond supplementExperimental Treatment1 Intervention
Participants will consume 32 g dry roasted, unsalted almonds twice a day for 12 weeks
Group II: Placebo matched supplementPlacebo Group1 Intervention
Participants will consume 100 g granola bar, calorie matched to Almond, twice a day for 12 weeks

Find a Location

Who is running the clinical trial?

Florida State UniversityLead Sponsor
199 Previous Clinical Trials
31,641 Total Patients Enrolled
17 Trials studying Obesity
1,418 Patients Enrolled for Obesity
Almond Board of CaliforniaOTHER
33 Previous Clinical Trials
2,021 Total Patients Enrolled
7 Trials studying Obesity
439 Patients Enrolled for Obesity
Bahram Arjmandi, PhDPrincipal Investigator - Florida State University
Florida State University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available in this trial for eligible participants?

"According to the clinicaltrials.gov webpage, this medical trial is actively enrolling participants under its current iteration which was initially published on March 2nd 2021 and most recently amended November 1st 2022."

Answered by AI

What are the fundamental goals of this trial?

"The primary objective of this clinical trial, which is scheduled to run over a course of 12 months, is assessing the effect that almonds have on functional performance. Secondary endpoints include examining the influence almond consumption has on lean body mass (assessed by dual energy x-ray absorptiometry), arterial health using flow mediated dilation (measured with a Philips HD11XE Doppler Ultrasound device and brachial artery linear array transducer) as well as pulse wave velocity (a vice employed by an Omron Healthcare Inc.'s VP-2000 unit to measure arterial stiffness in m/sec)."

Answered by AI

Does the protocol of this medical experiment admit new participants?

"This clinical experiment is aiming to enlist 50 participants aged between 50 and 59 who are overweight. Criteria for joining includes no limitations based on ethnicity, race or financial status, active lifestyle (with at least 30 minutes of exercise 3 days a week), and BMI measuring from 25.0 kg/m2 to 29.9 kg/m2; excluding individuals with chronic illnesses such as cancer."

Answered by AI

Are participants over 45 years of age eligible to join this medical trial?

"The ideal participants for this medical trial are between 50 and 59 years of age."

Answered by AI

How many participants are being recruited to take part in this clinical trial?

"Affirmative. According to information published on clinicaltrials.gov, this research is actively recruiting patients and was initially posted on the 2nd of March 2021. As of November 1st 2022, it requires 50 volunteers from a single medical site."

Answered by AI

Who else is applying?

What site did they apply to?
Florida State University
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
1

Why did patients apply to this trial?

I do not want to convert to diabetes and I want to stay very healthy.
PatientReceived 1 prior treatment
~3 spots leftby Jun 2024